Supplier Type
- Manufacturer
- contract manufacturer
- Trader
- custom synthesis
- Reagent
Supplier Region
- Ahmedabad(3)
- Hyderabad(23)
- Gujarat(94)
- Maharashtra(145)
- Kerela(2)
- AndhraPradesh(3)
- New Delhi(20)
- Mumbai(16)
- Telangana(68)
- Madhya Pradesh(10)
- Tamil Nadu(8)
- Uttar Pradesh(7)
- Karnataka(17)
- Rajasthan(4)
- Bangalore(3)
- Punjab(4)
- Haryana(3)
- Vadodara(2)
- West Bengal(4)
- GOA(1)
- Pune(1)
- Kolkata(1)
- Andhra Pradesh(2)
- Himachal Pradesh(1)
- NaviMumbai(1)
Purity
- USP
- IP/BP/USP
- IP/BP/EP/USP
- IP / BP
- IH
- 99.55
- 99.50 %
- 99% Min
- 99%
- 98+
- 98%
- >98%
- 96%
- 90 % Above
- 0.98
Package
- 1001100mg and 1 g
- 0Metric Ton
- 1grms kgs amd MT
- 1grms to kgs
- 1grms kgs and MT
- 102510 Kg / 25 Kg
- 0Customized pack size availaible
- 0Std Packing
- 10g
- 25g
- 50g
- 100g
- 50kg
- 100kg
- 25kgs
- 50kgs
- 255025 to 50 kg
- 1 kg
- 10 kg
- 25125kg and 1 MT
- 100500100mg or 500 mg
- 50010500 mg and 1.0 gm
- 25mg
- 50mg
- 100mg
- 250mg
- 1kg
- 5kg
- 10kg
- 20KG
- 25kg
- 1MT
- 5 kg
-
Methotrexate Related Compound E (50 mg) (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
70844-48-3
-
3S, 5S enantioMer of Atorvastatin CalciuM
1105067-88-6
-
2-{[4-(3-Methoxypropoxy)-3-methylpyridine-2-yl]methylthio}-1H-benzimidazole
117977-21-6
-
1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine
120014-07-5
-
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha)]-
41411-66-9
-
CloMipraMine Related CoMpound C
-
4-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfamide
16673-34-0
-
OLANZAPINE N-OXIDE
174794-02-6
-
GLIMEPIRIDE RELATED COMPOUND C (20 MG) (GLIMEPIRIDE URETHANE)
119018-30-3
-
3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
32943-25-2
Methotrexete Related Compound E 70844-48-3
100mg and 1 g 50mg 25mg
Atorvastatin Related compound E 1105067-88-6
Glyburide Related Compound A 16673-34-0
Moxifloxacin hydrochloride 186826-86-8
Moxifloxacin hydrochloride 186826-86-8